Metastasis-directed stereotactic body radiotherapy (SBRT) administered alone was associated with meaningful systemic therapy-free survival (STFS), with particular benefit in patients with oligometastatic prostate or renal cell cancer, according…
SBRT Alone Yields Significant STFS, Manageable Toxicity in Oligometastatic Cancer
